Package 71209-030-05

{"route": ["ORAL"], "spl_id": "efa28dcf-77d5-4fb2-b6c0-4939a9bf4766", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["41X3PWK4O2"], "rxcui": ["311919", "314142"], "spl_set_id": ["c678b772-acba-4b59-a0b2-d70d84283425"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, COATED in 1 BOTTLE (71209-030-04)", "package_ndc": "71209-030-04", "marketing_start_date": "20201217"}, {"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE (71209-030-05)", "package_ndc": "71209-030-05", "marketing_start_date": "20140210"}], "brand_name": "Nateglinide", "product_id": "71209-030_efa28dcf-77d5-4fb2-b6c0-4939a9bf4766", "dosage_form": "TABLET, COATED", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "71209-030", "generic_name": "Nateglinide", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nateglinide", "active_ingredients": [{"name": "NATEGLINIDE", "strength": "60 mg/1"}], "application_number": "ANDA206432", "marketing_category": "ANDA", "marketing_start_date": "20140210", "listing_expiration_date": "20261231"}